J. L. Bainbridge & Co »

Biogen Idec shares owned by J. L. Bainbridge & Co

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by J. L. Bainbridge & Co from 13F filings

Historical chart of J. L. Bainbridge & Co investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by J. L. Bainbridge & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by J. L. Bainbridge & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $24M 121k 193.84
2024-03-31 $11M 50k 215.63

More positions owned by J. L. Bainbridge & Co

Microsoft Corp Stock (MSFT)
Apple Stock (AAPL)
Eaton Corp Stock (ETN)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Goldman Sachs Group Stock (GS)
Amazon Stock (AMZN)
Delta Air Lines Inc Del Stock (DAL)
American Express Stock (AXP)
The Cigna Group Stock (CI)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Fiserv Stock (FI)
Qualcomm Stock (QCOM)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Taiwan Semiconductor Mfg Adr (TSM)
Blackstone Stock (BX)

View all positions for J. L. Bainbridge & Co

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
BlackRock
State Street Corporation
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Geode Capital Management
T. Rowe Price Associates
Beutel, Goodman & Company
Invesco
Morgan Stanley
Goldman Sachs Group
Northern Trust
RA Capital Management

View all funds holding Biogen Idec